Lv4
584 积分 2024-08-09 加入
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
[Chinese expert consensus on the systemic treatment of advanced clear cell renal cell carcinoma (2024 edition)]
3个月前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
3个月前
已完结
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
4个月前
已完结
[Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)]
4个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
4个月前
已完结
Expression of TRAIL and TRAIL receptors in normal and malignant tissues
4个月前
已完结
2025 FDA approvals
5个月前
已完结
The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma
5个月前
已完结
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial
6个月前
已完结
皖公网安备34019202002308
